Login / Signup
In silico Evaluation of NO-Sartans against SARS-CoV-2.
Negar Omidkhah
Farzin Hadizadeh
Razieh Ghodsi
Prashant Kesharwani
Amirhossein Sahebkar
Published in:
Current drug discovery technologies (2024)
evaluations are necessary for the drug development process.
Keyphrases
</>
sars cov
molecular docking
respiratory syndrome coronavirus